Slingshot members are tracking this event:
VIVUS Announces Intent to Reacquire U.S. and Canadian Rights for Stendra (Avanafil) from Endo
Slingshot Insights Explained
Dec 31, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Stendra, Commercial Rights, Rule 14e-2